People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Other Health Care, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EndoShape, Inc. | — | Other Health Care | Series A | $28.7M | $80.7M | 2011 |
| Oberon FMR, Inc. | — | Other | Series A | $24.0M | $85.0M | 2011 |
| Mosaic Biosciences, Inc. | — | Biotechnology | Series A | $14.7M | $176.4M | 2011 |
| ViroCyt, LLC | — | Other Health Care | Series A | $14.3M | $70.0M | 2012 |
| Sinopsys Surgical, Inc. | — | Biotechnology | Series A | $10.2M | $298.5M | 2011 |
Mark Lupa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Lupa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Kline | 2 | 6 |
| Dan Mitchell | 2 | 2 |
| Richard Ferrari | 1 | 15 |
| Jack Ball | 1 | 10 |
| Dan Watkins | 1 | 8 |
| Augustine Lawlor | 1 | 8 |
| Tim Wilson | 1 | 7 |
| Bryan Grulke | 1 | 4 |
| Shawn Fojtik | 1 | 4 |
| Nassim Usman | 1 | 4 |
| Guy Katsav | 1 | 3 |
| Eric Furfine | 1 | 3 |
| Robert Di Scipio | 1 | 3 |
| Walter Young | 1 | 3 |
| Jeanette Welsh | 1 | 3 |
| David Tze | 1 | 2 |
| Kathy Rowlen | 1 | 2 |
| Mark J. Lupa | 1 | 2 |
| Lee Geist | 1 | 2 |
| Robin Shandas | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.